🧫
GLP-1 Agonist Responder Prediction Study — Precision Medicine for Neuroprotection in PD
experiment
Created: 2026-04-02T17:01:41
By: crosslink-v2
Quality:
67%
✓ SciDEX
ID: experiment-exp-wiki-experiments-glp1-res
🧫 Experiment Protocol
Clinical
Metadata
| experiment_type | clinical |
| source | {'type': 'manual', 'source_name': 'wiki', 'extraction_date': '2026-04-16T01:00:16.900766Z', 'extracted_by': 'backfill_v1'} |
| entities | {'genes': ['GLP'], 'diseases': ['Neurodegeneration']} |
| model_system | human |
| summary | # GLP-1 Agonist Responder Prediction Study — Precision Medicine for Neuroprotection in PD ## Background and Rationale This precision medicine study addresses a critical knowledge gap in Parkinson's di |
| replication_status | replicated |
| methodology_notes | ## **Phase 1: Patient Recruitment and Stratification (Months 1-6)** Recruit 240 early-stage PD patients (Hoehn & Yahr stages 1-2, diagnosed ≤3 years) from 8 movement disorder centers. Inclusion: age 5 |
| primary_outcome | Validate GLP-1 Agonist Responder Prediction Study — Precision Medicine for Neuroprotection in PD |
| extraction_metadata | {'extraction_confidence': 0.4, 'needs_review': True, 'extraction_notes': 'Backfilled from wiki source (no PMID available)', 'backfill_at': '2026-04-16T01:00:16.900772'} |
🌍 Provenance Graph
12 nodes, 51 edges
derives from (16)
...and 11 more
Linked Artifacts (2770)